Featuring Nizar M. Tannir, MD, FACP (Course Director), Matthew Campbell, MD, MS, Toni K. Choueiri, MD, Lauren C. Harshman, MD
Join these clinical experts for an intimate discussion of the latest scientific evidence and future perspectives related to advances in immuno-oncology mono- and combination therapies for renal cell carcinoma, and the potential subsequent implications for practice and patient care.
Earn 1.0 AMA PRA Cateogy I Credit™
Novel Immuno-oncology Combination Therapies for Renal Cell Carcinoma: Evolving Considerations for Clinical Practice
This Peer-to-Peer Education Kit provides access to turnkey resources, including a Power Point Slide Presentation, a comprehensive Discussion Guide, and an international News Digest. The slide presentation includes key slides from an Expert Panel of clinicians in the field, as well as a Discussion Guide that provides thought-provoking questions for you to address with your colleagues on how best to incorporate these new agents and combinations in your specific clinical practice, especially as the data are still evolving.
Discussion Guide Available in 6 Languages!
Jointly provided by AKH Inc. and ASiM CE LLC.
This activity is supported by educational grants from Pfizer, Inc and EMD Serono.